Premium
Sneddon–Wilkinson disease treated with etanercept: report of two cases
Author(s) -
Berk D. R.,
Hurt M. A.,
Mann C.,
Sheinbein D.
Publication year - 2009
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.2008.02905.x
Subject(s) - etanercept , medicine , dapsone , acitretin , dermatology , refractory (planetary science) , disease , pyoderma gangrenosum , surgery , tumor necrosis factor alpha , psoriasis , physics , astrobiology
Summary Sneddon–Wilkinson disease (SWD), also known as subcorneal pustular dermatosis, is a rare, chronic eruption that is often difficult to treat, particularly in patients who do not respond to or cannot tolerate dapsone. Few case reports exist of patients with SWD treated with antitumour necrosis factor‐α therapy. We report two patients with SWD refractory to numerous treatments, who responded to etanercept (in combination with low‐dose acitretin in one case).